Clinical trial / 2015
Adding 2.0 g/day of plant sterols to lipid-lowering therapies further reduced total and LDL cholesterol without altering absorption or synthesis markers.
In an 86-patient randomized trial, participants completed a 4-week run-in on atorvastatin 10 mg, followed by 4 weeks on atorvastatin 40 mg, ezetimibe 10 mg, or both. In the next 4-week phase, 2.0 g of plant sterols were added to these treatments. Adding plant sterols further reduced total and LDL cholesterol by ~7.7% and 6.5%, respectively, in the atorvastatin group, and by 5.0% and 4.0% in the combination therapy group (P < .05 for all). Plant sterol supplementation produced no additional effects on markers of cholesterol absorption or synthesis.
- Study type
- Randomized, open-label, parallel-arm trial with blinded endpoints
- Who was studied
- 86 male and female patients on lipid-lowering therapy
- What was measured
- LDL cholesterol, total cholesterol, and markers of cholesterol synthesis and absorption
THE PAPER
Additive effects of plant sterols supplementation in addition to different lipid-lowering regimens.
Malina DM, Fonseca FA, Barbosa SA, Kasmas SH, Machado VA, França CN, Borges NC, Moreno RA, Izar MC. J Clin Lipidol, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.